Mario E. Lacouture, MD
Photo: 秘密研究所 Langone Staff
After a national search, 秘密研究所 Langone Health is pleased to announce that Mario E. Lacouture, MD, has been named the new chief of the Division of Dermatology at 秘密研究所 Langone Hospital鈥擫ong Island. Dr. Lacouture received an academic appointment as professor in the at 秘密研究所 Grossman Long Island School of Medicine and also now serves as the medical director of the Symptom Management Program at Perlmutter Cancer Center at 秘密研究所 Langone Hospital鈥擫ong Island.
鈥淲e are pleased to have Dr. Lacouture joining us as a foremost expert in oncodermatology, a subspecialty that focuses on the dermatological side effects of cancers and how to manage these symptoms in patients,鈥 said Joseph J. Greco, MD, executive vice president and chief of hospital operations at 秘密研究所 Langone Hospital鈥擫ong Island.
鈥淭he opportunity to lead 秘密研究所 Langone Dermatology on Long Island aligns with my commitment to high-quality, accessible care and my fondness for the people of the island,鈥 said Dr. Lacouture. 鈥淚n addition, at Perlmutter Cancer Center, I will build on our experience improving patients鈥 quality of life by preventing and treating skin issues during treatment, so that now more people can access our compassionate, specialized care for side effects, with a focus on the whole patient.鈥
Before joining 秘密研究所 Langone, Dr. Lacouture was an attending physician and the program director of oncodermatology and research in the Dermatology Service at Memorial Sloan Kettering Cancer Center, in Manhattan. He was also a professor in the Department of Dermatology at Weill Cornell Medicine in New York.
After receiving his medical degree from Javeriana University in his native country of Colombia, Dr. Lacouture completed a postdoctoral research fellowship in immunology at Brigham and Women鈥檚 Hospital in Boston. He then trained as an intern in general surgery at Cleveland Clinic, followed by a residency in dermatology at the University of Chicago. At Northwestern University in Chicago, Dr. Lacouture created the first clinical and research program in oncodermatology, a distinct subspecialty within dermatology and oncology that is dedicated to the science and care of skin, hair, and nail conditions in patients with cancer and survivors. This oncodermatology model has been adopted by nearly 70 percent of National Comprehensive Cancer Centers.
The author of more than 300 medical publications, Dr. Lacouture is also the editor of the textbook Dermatologic Principles and Practice in Oncology and the author of Dr. Lacouture鈥檚 Skin Care Guide for People Living with Cancer. He oversees the most extensive portfolio of clinical trials in oncodermatology and was the principal investigator for the STEPP trial鈥攁 practice-changing study in the prevention of skin side effects due to antibodies targeting the epidermal growth factor receptor in cancer鈥攁nd the CHANCE study, which defined skin, hair, and nail aftereffects from treatments in patients who had breast cancer. He is also the co-principal investigator of a cooperative agreement (U01) with the National Cancer Institute and National Institute of Arthritis and Musculoskeletal and Skin Diseases for a research project investigating therapeutic targets to treat side effects from immunotherapies.
Dr. Lacouture is a past member of the board of directors and a former chair of the Oncodermatology Study Group for the Multinational Association of Supportive Care in Cancer and is currently on the Guidelines Committee of the American Society of Clinical Oncology. In 2021, Dr. Lacouture founded the Oncodermatology Society and now serves as its inaugural president. Since 2014, he has been named in Castle Connolly鈥檚 鈥淭op Doctors鈥 series for the New York metro area.
Media Inquiries
Rosemary Gomez
Office: 516-663-2709
Cell: 516-402-4260
Rosemary.Gomez@秘密研究所Langone.org
